Catalent opens newest clinical supply site in Japan, expanding its footprint in the Pacific Rim
New Jersey powerhouse CDMO Catalent has opened its newest clinical supply facility in Shiga, Japan.
The facility will help Catalent expand its Asia-Pacific network, and adds to the two sites it already has in China, as well as another in Singapore, to help serve patients’ clinical trials across the region. It’s 6,000 square meters — what Catalent says is the largest of its kind in Japan — and was acquired from Teva/Takeda Pharmaceuticals in 2020. Catalent spent the last year redeveloping the site.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
